STAT inhibitors are drugs which target signal transducer and activator of transcription (STAT) proteins, a family of cytoplasmic induction factors. Inhibitors of STAT proteins are being developed for use in cancer therapy.
See also
References
- Furqan, Muhammad; Akinleye, Akintunde; Mukhi, Nikhil; Mittal, Varun; Chen, Yamei; Liu, Delong (2013-12-05). "STAT inhibitors for cancer therapy". Journal of Hematology & Oncology. 6: 90. doi:10.1186/1756-8722-6-90. ISSN 1756-8722. PMC 4029528. PMID 24308725.
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |